Hospital de Clínicas de Porto Alegre - HCPA/UFRGS

Esophageal cancer

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. - FORTITUDE-102 - AmgenSee more

Gastric cancer

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. - FORTITUDE-102 - AmgenSee more

Gastroesophageal cancer

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. - FORTITUDE-102 - AmgenSee more

Lupus

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus - ALLEGORY - Hoffmann-La RocheSee more

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-1 - BiogenSee more

Myeloproliferative syndromes

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment - MYF3001 - Geron CorporationSee more

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis - Telios Pharma, Inc.See more

Arthritis

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) - I4V-MC-JAHU - Eli Lilly and CompanySee more

Bladder Cancer

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder - SunRISe-2 - Janssen Research & Development, LLCSee more

Colorectal cancer

Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait - CCHOWW - Hospital Alemão Oswaldo CruzSee more

Diabetes

Effect of Partial Dietary Replacement From Animal to Plant-Based Protein for Type 2 Diabetes Management - Hospital de Clinicas de Porto AlegreSee more

Diffuse sclerosis

A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms - VITALISScE™ - Boehringer IngelheimSee more

Fibromyalgia

Cortical Excitability Modulation With ctDCS in Fibromyalgia. - ctDCS - Hospital de Clinicas de Porto AlegreSee more

Heart failure

Sensation of Dyspnea and Experience of Patients With Heart Failure - MOVE - Hospital de Clinicas de Porto AlegreSee more

Leukemia

PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia - Syneos HealthSee more

Nephropathy

A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression - IMAGINATION - Hoffmann-La RocheSee more

Obesity

Effect of Partial Dietary Replacement From Animal to Plant-Based Protein for Type 2 Diabetes Management - Hospital de Clinicas de Porto AlegreSee more

Solid tumors

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors - Genentech, Inc.See more